|
Recurrent Urethral Cancer
Current Clinical Trials
Standard treatment options for female/male recurrent urethral cancer:
-
Locally recurrent urethral cancer after radiation therapy should be treated
by surgical excision.
- Locally recurrent urethral cancer after surgery alone should be considered
for combination radiation and wider surgical resection.[1]
Treatment options under clinical evaluation:
- Metastatic urethral cancer should be considered for clinical trials using
chemotherapy. Early evidence suggests that transitional cell cancer of the
urethra may respond favorably to the same chemotherapy regimens employed for
advanced transitional cell cancer of the bladder.
Current Clinical Trials
Check for U.S. clinical trials from NCI's PDQ Cancer Clinical Trials Registry that are now accepting patients with recurrent urethral cancer. The list of clinical trials can be further narrowed by location, drug, intervention, and other criteria.
General information about clinical trials is also available from the NCI Web site.
References
-
Scher HI, Yagoda A, Herr HW, et al.: Neoadjuvant M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for extravesical urinary tract tumors. J Urol 139 (3): 475-7, 1988.
[PUBMED Abstract]
 Back to Top
< Previous Section | Next Section > |
